Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lower IGF-1 levels may be linked to hair loss in women.

Lower IGF-1 levels may be linked to hair loss in women.

Trichoscopy is useful for diagnosing and monitoring male pattern hair loss.

AI in alopecia research needs better tools for predicting treatment outcomes and ensuring fairness.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

FemmeBalance supplement significantly improved PMS symptoms in women.

Higher substance P levels may cause discomfort in hair loss patients.

Alopecia is common in severe cases of autosomal recessive congenital ichthyosis.

Transfer learning with three neural network architectures accurately classifies hair diseases.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Nail changes in kids with stubborn alopecia areata often happen with longer illness but aren't linked to how much hair is lost.

CEOs aged 50-69 have less significant hair loss than the general white male population.

CEOs aged 50-69 have less significant hair loss than the general white male population.

ADSC injections improve hair density, thickness, and reduce inflammation in female pattern hair loss.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.